are you sure mate, embargos usually commence when abstracts with new data are accepted for presentation,
that way the conference shares with the company the first release news and gives the conference added
publicity....Embargos are usually lifted when the conference starts.....As far as I can see, at this stage there
is no indication of Immutep presenting at AACR.....
Ann: Immutep Clinical Update & Results Global Webcast Slides, page-73
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.005(1.59%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.0¢ | 30.5¢ | $922.9K | 2.963M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 149460 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |